7.56

3.32% -0.26

Instil Bio Inc (TIL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$7.82

Offen:

$7.66

24-Stunden-Volumen:

927

Relative Volume:

0.08

Marktkapitalisierung:

$51.61M

Einnahmen:

Nettoeinkommen (Verlust:

$-71.37M

KGV:

-0.7014

EPS:

-10.7782

Netto-Cashflow:

$-46.62M

1W Leistung:

-1.63%

1M Leistung:

+2.02%

6M Leistung:

-15.06%

1J Leistung:

-70.33%

1-Tages-Spanne:

$7.51

$7.66

1-Wochen-Bereich:

$7.50

$7.82

52-Wochen-Spanne:

$5.67

$26.48

Instil Bio Inc Stock (TIL) Company Profile

Firmenname

Instil Bio Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

(972) 499-3350

Adresse

3963 MAPLE AVENUE, DALLAS

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-12

Neueste SEC-Einreichungen

TIL's Discussions on Twitter

Compare TIL vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TIL Instil Bio Inc	7.61	53.04M	0	-71.37M	-46.62M	-10.78
VRTX Vertex Pharmaceuticals Inc	522.74	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	804.43	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,005.05	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.68	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.07	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-07	Herabstufung	H.C. Wainwright	Buy → Neutral
2026-01-06	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-01-07	Hochstufung	Jefferies	Hold → Buy
2024-11-04	Eingeleitet	JMP Securities	Mkt Perform
2024-04-12	Herabstufung	Jefferies	Buy → Hold
2022-11-01	Herabstufung	Cowen	Outperform → Market Perform
2022-11-01	Herabstufung	Truist	Buy → Hold
2021-08-13	Eingeleitet	Robert W. Baird	Outperform
2021-04-13	Eingeleitet	Cowen	Outperform
2021-04-13	Eingeleitet	Morgan Stanley	Equal-Weight
2021-04-13	Eingeleitet	Truist	Buy

Alle ansehen

Instil Bio Inc Aktie (TIL) Neueste Nachrichten

Sep 04, 2026

Press Release: Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Moomoo

Sep 04, 2026

(TIL) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Sep 04, 2026

Aug 16, 2026

TIL Should I Buy - Intellectia AI

Aug 16, 2026

Aug 14, 2026

Why (TIL) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Aug 14, 2026

Aug 13, 2026

Instil Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results - Intellectia AI

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 13, 2026

Instil Bio Reports $4.3 Million Second-Quarter 2026 Net Loss - Quiver Quantitative

Aug 13, 2026

Instil Bio, Inc. 2026: Revenue ($4.35M), Net income ($4.3M), EPS ($0.63) — 10-Q Summary - TradingView

Aug 13, 2026

Instil Bio reports Q2 2026 net loss $4.3M, cash and marketable securities $69.9M - TradingView

Aug 13, 2026

Instil Bio (TIL) slashes R&D spend and leans on Tarzana lease income in Q2 2026 - Stock Titan

Aug 13, 2026

Instil Bio expects $69.9M cash to fund plan beyond 2027 - Stock Titan

Aug 13, 2026

Instil Bio (Nasdaq: TIL) trims Q2 2026 loss and extends cash runway - Stock Titan

Aug 13, 2026

Instil Bio (TIL) Dips 2.7% as Shares Hover Near Key SupportJurik MA - vinanet.vn

Aug 13, 2026

Aug 12, 2026

TIL Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Pipeline Execution Takes Center StageEarnings Volatility Report - vinanet.vn

Aug 12, 2026

Aug 11, 2026

Instil Bio (TIL) Edges Higher: Biotech Stock Holds Above Key SupportHigh Volume Stocks - dars.gov.et

Aug 11, 2026

Aug 10, 2026